Tekcapital’s Guident files updated S-1 in preparation for NASDAQ IPO

Tekcapital portfolio company Guident has filed an updated S-1 form with the SEC, signalling preparations for its NASDAQ IPO are gathering pace.

The autonomous vehicle technology company filed its original S-1 confidentially towards the end of the summer, but was likely held up by the longest US government shutdown in history.

The SEC is reportedly facing a substantial backlog of filings, meaning a swathe of companies, including Guident, are waiting to progress with their listing plans.

Material details of the S-1 filed yesterday in the US were largely unchanged, with the indicative price range remaining at between $7.80 and $9.80.

While the delay will be frustrating for Tekcapital and Guident stakeholders, it may have been a blessing in disguise, as it means the firm has sidestepped market volatility during November.

Tekcapital holds around a 70% stake in Guident, which could be worth more than Tekcapital’s entire market cap when Guident lists.

The backlog at the SEC has created an opportunity for Guident to provide further details of commercial progress ahead of the IPO, such as the recent launch of a fresh MiCa autonomous shuttle deployment in Boca Raton.

“This launch marks a defining moment for Boca Raton and for the future of driverless mobility,” Harald Braun, Chairman and CEO of Guident at the time of the launch.

“The MiCa is managed by Guident’s RMCC platform, which bridges technology and human judgment, ensuring that every autonomous journey is monitored, secure, and safe.”

Occuity Builds Commercial Momentum as it Turns Innovation into Reality

Building on its groundbreaking work in Oculomics, UK MedTech innovator Occuity is now moving from concept to commercial success, turning its patented optical platform into real products, revenue and global partnerships. 

Founded with a mission to make health screening and disease monitoring simpler, faster and pain free, Occuity’s technology uses light to scan through the eye and analyse the reflections returned. This enables clinicians to take precise measurements or identify early biomarkers of disease without ever touching the eye. 

Real products, real markets 

Occuity’s first device, the PM1 Pachymeter, is now CE Marked and commercially available and generating revenue through a growing global network of 19 distributors. The PM1 enables fast, contact-free measurement of corneal thickness, a key parameter in the screening and management of glaucoma, one of the leading causes of blindness worldwide. 

Building on that success, the company is advancing development of its next device, the AX1 Axiometer, designed for use in the rapidly expanding myopia management market, forecast to reach US $11.7 billion by 2030. With myopia soon to be affecting around half of the global population, the AX1 aims to provide eye-care professionals with a simple, handheld device for measuring axial length – the key biomarker in managing short-sightedness. 

A scalable platform for growth 

What sets Occuity apart is that all of these devices are built upon the same optical platform described in the company’s earlier feature. This shared foundation allows faster product development, more efficient regulatory pathways and a sustainable commercial model. Each new device strengthens the platform, widening its application across ophthalmology and systemic disease detection. 

This platform approach is key to Occuity’s long-term strategy, providing opportunities not only for device sales but also for future data-driven insights and diagnostics that could transform healthcare delivery. 

Global reach and strong IP 

Occuity’s technology has already attracted international attention, with partnerships across Europe, the Middle East and Asia. Its 15 patent families – covering optical design, scanning systems and alignment methods – create significant barriers to entry and reinforce its competitive edge. 

As CEO Dan Daly explains: 
“Our goal has always been to make advanced diagnostic technology more accessible. The PM1 and AX1 are just the beginning. The same core technology will power our future devices for diabetes and Alzheimer’s, helping clinicians identify disease earlier, faster and without pain or inconvenience.” 

Building momentum and investor confidence 

Occuity’s transition from R&D to commercial traction comes at a pivotal time. With its Republic Europe crowdfunding campaign now live, investors have the opportunity to back a company that has proven its technology, established early revenue and built a clear roadmap to scale. 

For those seeking exposure to global healthcare markets and the growing field of Oculomics, Occuity offers a compelling combination of innovation, defensibility and purpose. 

With its crowdfunding campaign live on Republic, if you’re looking for an ethical investment opportunity which offers exciting potential returns, you can learn more about Occuity here

Disclosure: This article is for information only and does not constitute investment advice. Capital is at risk. 

YouGov: the votes are in or are they? Will tomorrow’s AGM count?

Early tomorrow morning, at 8.30am, should see the global pollster group YouGov (LON:YOU) hold its AGM covering the Report & Accounts for the year to end-July. 
It will be interesting to note whether there is a published AGM Trading Update, however the odds are against such an occurrence. 
That is a shame because investors need to see and hear as much corporate newsflow as is possible, thereby creating anticipation of beneficial progress, while pillowing against any shock developments. 
Whatever occurs I have to say that I do get a good feel for this £300m-capitalised group’s...

Bloomsbury Publishing partners with Google to integrate AI

Bloomsbury Publishing has unveiled a strategic collaboration with Google Cloud to integrate artificial intelligence into its operations and educational platforms.

The deal will see Bloomsbury combine its publishing expertise with Google Cloud’s AI technologies, including NotebookLM, Vertex AI, and Gemini Enterprise.

Gemini represents Google’s most advanced multimodal AI models, whilst LearnLM is specifically designed for learning applications.

Nigel Newton, founder and chief executive of Bloomsbury, said the collaboration would “demonstrate how cutting-edge technology can increase the discovery and sales of books, as well as transform engagement with content to improve learning outcomes.”

The partnership holds particular significance for Bloomsbury’s Academic Division. Bloomsbury Digital Resources, which leads the company’s digital innovation efforts, will deploy AI tools to enhance discovery and engagement as the educational sector increasingly adopts AI-powered platforms and personalised learning technologies.

Beyond education, the collaboration will target operational efficiencies across Bloomsbury’s entire business. For example, hopes are that advanced AI infrastructure will enable data-driven insights and semantic search, improving trend analysis and boosting book sales.

“This collaboration demonstrates how Google Cloud’s advanced AI capabilities, including Vertex AI and Gemini Enterprise, can empower leading organizations to transform their industries,” said Debbie Weinstein, President of Google in Europe, Middle East and Africa.

“We look forward to helping Bloomsbury revolutionise content discovery, enhance learning, and drive significant business growth through intelligent, scalable solutions.”

Beeks Financial Cloud announces two contract wins

Beeks Financial Cloud Group has won two significant contracts worth a combined £3.4m, which will maintain the company’s sales momentum into the second half of its financial year.

The cloud computing and connectivity provider has signed a three-year Private Cloud contract with a major Canadian bank valued at $1.5m. It has also secured a £2m extension of its Proximity Cloud with a large FX broker. This takes the total value of that particular contract to £4m over five years.

Revenue from both agreements is expected to begin in the second half of FY26 and build on an encouraging start to the year.

“As described at the time of our Final Results, we have a wide range of opportunities progressing through our sales pipeline across the breadth of our product offering, demonstrating the growing appetite for our cloud computing and connectivity solutions across the global financial markets,” said Gordon McArthur, CEO at Beeks.

“With the proof of concept for our newest offering, Market Edge Intelligence, progressing to plan, opening up a significant additional market for the Group, and Exchange Cloud contracts with major exchanges approaching completion, we remain confident in continued momentum across our business.”

Beeks recently announced 26% revenue growth in the year to 30 June 2025.

Adsure Services: AI tool deployment and orderbook expansion

Adsure Services CEO Kevin Limn speaks with Jeremy Naylor. Adsure Services is a leading audit and assurance services provider, dedicated to delivering high-quality financial review and compliance solutions. Through investment in innovative technology and AI-driven solutions, Adsure is focused on enhancing efficiency and accuracy in the audit sector. Kevin outlines the group’s plans for growth including the launch of the TIAA Insight tool.

FTSE 100 gains as banks pass stress tests

The FTSE 100 was on the front foot on Tuesday as strong banking stress tests boosted UK-centric sectors, including banks, retailers and housebuilders.

As the final month of the year gets underway, the FTSE 100 seems content with bouncing around the 9,700 mark in early trade before the bulls took control and pushed the index 0.4% higher.

Banks were among the top risers after the sector passed the latest set of stress tests with flying colours. Barclays, Lloyds, and Natwest were all higher by more than 1% at the time of writing.

But there were also winners away from the banking sector. Persimmon rose 1% on hopes that banks may increase lending activity and spur additional housing activity, while similar sentiment around lending saw DIY retailer Kingfisher higher on the day.

“The UK’s seven biggest banks sailed through the latest stress test, reaffirming their resilience and earning a regulatory nod to ease capital buffers,” said Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“Most banks already hold capital well above the minimum by choice, so any shift in strategy may take time – but in theory, it frees up extra capital for lending or capital returns.”

“However they use the new freedom, this is another clear signal that the UK banking sector is in robust health. This was largely expected, but the confirmation should still be taken well, especially after dodging tax hikes in last week’s Budget.”

Broker ratings also played a part in trading on Tuesday. Berkeley Group was unable to join the housebuilder rally after RBC downgraded its rating to underperform from outperform and cut its price target to 3,700p from 4,900p. Berkeley shares were down 1.6% at the time of writing.

Persimmon, coincidentally, was upgraded by RBC to outperform with a price target of 1,750p. Persimmon currently changes hands at 1,347p.

Polar Capital Technology Trust was 1.4% higher, with a 0.4% gain in NASDAQ futures pointing to a strong session ahead for US tech shares.

After a storming rally yesterday, gold miner Endevaour was the FTSE 100 top faller after the group set out a 5-year plan to boost production through exploration. However, this will come at a $100m cost, which investors don’t seem to be over the moon about.

AIM movers: Pantheon Resources still hopeful and Petards defence contract

1

Security and surveillance company Petards (LON: PEG) has been awarded a defence contract worth £2.2m by Rheinmetall BAE Systems Land. Rheinmetall BAE Systems Land. This contract is part of the Challenger tank upgrade programme, and it will be delivered by the end of 2026. The share price jumped 43.3% to 10.75p.

Shares in Synergia Energy (LON: SYN) recovered 18.8% to 0.0095p following yesterday’s news that it is selling its 50% stake in the Cambay PSC for $14m and $500,000 has already been received. The initial payment is $6.5m with a further $7m 12 months after completion. This deal requires India government approval. Synergia Energy is asking for shareholder approval to leave AIM, and it will return cash to shareholders via a share buyback. A matched bargain facility may be put in place. The share price is still more than two-fifths lower this week.

Defence business RC Fornax (LON: RCFX) has gained £2.5m of additional orders and that helps to underpin full year forecast revenues of £4.1m. In November £2.32m was raised at 6p/share. The share price gained 9.76% to 6.75p.

Fulcrum Metals (LON: FMET) has achieved more than 70% gold and silver recoveries at Teck Hughes in Canada. This is part of the phase 3 metallurgical work. Previous gold recovery levels were 59.4%. Full results are expected in the first quarter of 2026, and this will support a mineral resource estimate. This will be followed by a phase 4 preliminary feasibility study. The share price rose 1.85% to 6.875p, having been above 7.5p earlier in the morning.

FALLERS

Alaska-focused oil and gas explorer Pantheon Resources (LON: PANR) has updated the market on the flow testing of the Dubhe-1 well. Gas and modest amounts of light oil have been produced. Around two-fifths of the fluid used in fracking has been recovered. Management believes that flow ates may improve one more fluid is extracted. The estimated costs of the well have been raised from $25m to $33m. The share price dipped 19.9% to 20.275p.

Water and environmental testing technology supplier Metir (LON: MET) says demand is strong for its instruments and it is trying to increase the supply rate from its manufacturing partner. Investment in upgrading the instruments will enable more readily available components to be used, which will help to improve margins. There have been technical difficulties with some instruments that are part of a major project in Qatar and payments are deferred until the first quarter of 2026. Cash was £147,000 on 1 December and management believes that it has the funds it requires. The share price is 6.06% lower at 0.775p.

Data analysis software provider Celebrus Technologies (LON: CLBS) has annualised recurring revenues of $20.8m. It is still early days in the move to a subscription model. Interim revenues fell from $17.2m to $10.4m due to the model change. There was a swing from profit to a loss of $1.4m. Cash has reached $27.3m by September 2025. The dividend was raised 3% to 0.98p/share. Full year revenues ae expected to decline from $38.7m to $23.5m with a loss of $700,000 before a return to profit next year. The share price fell 5.26% to 135p.

Interim results from media research company System1 Group (LON: SYS1) were in line with the previous trading statement. Revenues fell 7% to £17.1m and pre-tax profit slumped to £300,000. The weakness was in the UK and Europe. There has been an improved start to the third quarter and there should be growth in the second half.  The share price declined 4.69% to 203p.

The Watches of Switzerland: Interims due this week, analyst ups TP to 550p

This coming Thursday, 4th December, will see The Watches of Switzerland Group (LON:WOSG) announce its Interim Results covering the 26 weeks to 26th October. 
The group, which is the UK's largest retailer for Rolex, OMEGA, Cartier, TAG Heuer and Breitling watches, despite retail sector challenges, enjoyed a strong first half.  
Following the group’s early November Trading Update and ahead of this week’s announcement broker’s analysts have shown a somewhat mixed reaction in their views of the £1.15bn-capitalised business, ranging from a 370p Target Price up to a 590p Buy Rating.&n...

Gooch & Housego: finals show 46.8% leap in profits, strong Order Book

This morning the £134m-capitalised photonics technology group Gooch & Housego (LON:GHH) declared its results for the year to end-September showing a stronger performance than expected performance. 
The company, which is a specialist manufacturer of optical components and systems, has already given a clear guidance that the last year progressed much as anticipated. 
It reported a strong financial year with revenue increasing by 10.7% to £150.5m and adjusted operating profit rising by 37.3% to £14.4m, leading to an adjusted profit before tax of £11.9m, up 46.8%.  
The com...